173 related articles for article (PubMed ID: 16220978)
1. Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity.
Georgsson J; Sköld C; Plouffe B; Lindeberg G; Botros M; Larhed M; Nyberg F; Gallo-Payet N; Gogoll A; Karlén A; Hallberg A
J Med Chem; 2005 Oct; 48(21):6620-31. PubMed ID: 16220978
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2006 Oct; 49(20):6133-7. PubMed ID: 17004728
[TBL] [Abstract][Full Text] [Related]
3. New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists.
Rosenström U; Sköld C; Plouffe B; Beaudry H; Lindeberg G; Botros M; Nyberg F; Wolf G; Karlén A; Gallo-Payet N; Hallberg A
J Med Chem; 2005 Jun; 48(12):4009-24. PubMed ID: 15943474
[TBL] [Abstract][Full Text] [Related]
4. Short pseudopeptides containing turn scaffolds with high AT2 receptor affinity.
Georgsson J; Rosenström U; Wallinder C; Beaudry H; Plouffe B; Lindeberg G; Botros M; Nyberg F; Karlén A; Gallo-Payet N; Hallberg A
Bioorg Med Chem; 2006 Sep; 14(17):5963-72. PubMed ID: 16753301
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.
Georgsson J; Sköld C; Botros M; Lindeberg G; Nyberg F; Karlén A; Hallberg A; Larhed M
J Med Chem; 2007 Apr; 50(7):1711-5. PubMed ID: 17358051
[TBL] [Abstract][Full Text] [Related]
6. A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2004 Feb; 47(4):859-70. PubMed ID: 14761188
[TBL] [Abstract][Full Text] [Related]
7. Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships.
Wu X; Wan Y; Mahalingam AK; Murugaiah AM; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
J Med Chem; 2006 Nov; 49(24):7160-8. PubMed ID: 17125268
[TBL] [Abstract][Full Text] [Related]
8. Modeling binding modes of angiotensin II and pseudopeptide analogues to the AT2 receptor.
Sköld C; Nikiforovich G; Karlén A
J Mol Graph Model; 2008 Feb; 26(6):991-1003. PubMed ID: 17936050
[TBL] [Abstract][Full Text] [Related]
9. Role of Phe308 in the seventh transmembrane domain of the AT2 receptor in ligand binding and signaling.
Pulakat L; Mandavia CH; Gavini N
Biochem Biophys Res Commun; 2004 Jul; 319(4):1138-43. PubMed ID: 15194486
[TBL] [Abstract][Full Text] [Related]
10. Effects of some new angiotensin II analogs on the reactivity of small arterioles in the mesentery of rat intestine.
Folwarczna J; Janiec W; Sliwiński L; Paruszewski R
Pol J Pharmacol Pharm; 1989; 41(6):585-9. PubMed ID: 2485905
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation.
Zhao Y; Foryst-Ludwig A; Bruemmer D; Culman J; Bader M; Unger T; Kintscher U
J Neurochem; 2005 Sep; 94(5):1395-401. PubMed ID: 15992368
[TBL] [Abstract][Full Text] [Related]
12. Selective peptide and nonpeptide ligands differentially bind to angiotensin II AT2 receptor and a non-angiotensin II CGP42112 binding site.
Ciuffo GM; Saavedra JM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1129-34. PubMed ID: 7562479
[TBL] [Abstract][Full Text] [Related]
13. Bicyclic tripeptide mimetics with reverse turn inducing properties.
Johannesson P; Lindeberg G; Tong W; Gogoll A; Karlén A; Hallberg A
J Med Chem; 1999 Feb; 42(4):601-8. PubMed ID: 10052967
[TBL] [Abstract][Full Text] [Related]
14. AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.
Johannesson P; Erdélyi M; Lindeberg G; Frändberg PA; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2004 Nov; 47(24):6009-19. PubMed ID: 15537355
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide contributes to AT2 but not AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles.
Baranov D; Armstead WM
Eur J Pharmacol; 2005 Nov; 525(1-3):112-6. PubMed ID: 16256981
[TBL] [Abstract][Full Text] [Related]
16. First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo.
Wan Y; Wallinder C; Johansson B; Holm M; Mahalingam AK; Wu X; Botros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Hallberg A; Alterman M
J Med Chem; 2004 Mar; 47(6):1536-46. PubMed ID: 14998339
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and AT2 receptor-binding properties of angiotensin II analogues.
Rosenström U; Sköld C; Lindeberg G; Botros M; Nyberg F; Hallberg A; Karlén A
J Pept Res; 2004 Nov; 64(5):194-201. PubMed ID: 15485557
[TBL] [Abstract][Full Text] [Related]
18. Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system.
Murugaiah AM; Wallinder C; Mahalingam AK; Wu X; Wan Y; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M
Bioorg Med Chem; 2007 Nov; 15(22):7166-83. PubMed ID: 17825570
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.
Wan Y; Wallinder C; Plouffe B; Beaudry H; Mahalingam AK; Wu X; Johansson B; Holm M; Botoros M; Karlén A; Pettersson A; Nyberg F; Fändriks L; Gallo-Payet N; Hallberg A; Alterman M
J Med Chem; 2004 Nov; 47(24):5995-6008. PubMed ID: 15537354
[TBL] [Abstract][Full Text] [Related]
20. Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction.
Turner CA; Cooper S; Pulakat L
Biochem Biophys Res Commun; 1999 Apr; 257(3):704-7. PubMed ID: 10208847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
